biote Corp.BTMDNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 86% recommend buying.

Consensus Rating

Buy

7 analysts·Limited coverage

86%

Rating Distribution

Strong Buy

00%

Buy

686%

Hold

114%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 120% higher.

Bear Case

$5.00

+120%

Consensus

$5.00

+120%

Bull Case

$5.00

+120%

Price Range7 analysts

Low

Consensus

High

$5.00

Current Target

Current Price

$2.27

Upside to Target

$2.73

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.40(2 analysts)

P/E2x

Current: 2.5x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+8.51%

EPS+63.29%

FY2028

Rev+21.19%

EPS+76.74%

FY2029

Rev+7.36%

EPS+7.02%

Earnings Surprises

Beat rate:92%(11/12 quarters)

Avg surprise:+194.5%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 7, 2026Truist Financial

Biote price target lowered to $5 from $6 at Truist

Target:$5.00

+96.9%from $2.54

Jun 21, 2024Truist Financial

Truist Securities Reiterates Buy Rating on biote Corp. (BTMD)

Target:$9.00

+24.5%from $7.23

Mar 13, 2024Jefferies

biote Corp. (BTMD) PT Raised to $8.24 at Jefferies

Target:$8.24

+35.3%from $6.09

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance